Predict falls using wearable technology
- Trial ID
- NCT07281755
- Official Title
- Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction
- Goal
- Predict falls using wearable technology
- Status
- RECRUITING
- Sponsor
- Northumbria University
- Study Type
- OBSERVATIONAL
- Enrollment
- 60 participants
- Conditions
- Parkinson Disease(PD)
Summary For Families
The team wants to validate wearable sensors that provide objective mobility measures and use those signals to predict falls in people with Parkinson's. Participants will wear small body sensors that record walking patterns, turns, balance and daily activity both in clinic tests and at home, and researchers will build and test algorithms that translate gait speed, step variability and sway into mobility scores and fall risk predictions. As an observational project, it does not change medications but records movement while people use their usual treatments. They are enrolling about 60 people age 50 and up with a Parkinson's diagnosis by a movement disorder specialist using UK Brain Bank criteria, Hoehn and Yahr stages I to III, MoCA score 21 or higher, able to stand and walk unassisted for two minutes, with no other neurological disorders or recent lower limb injury, and who can attend visits in Newcastle upon Tyne.
Locations
- Northumbria University, Newcastle upon Tyne, United Kingdom
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The team wants to validate wearable sensors that provide objective mobility measures and use those signals to predict falls in people with Parkinson's. Participants will wear small body sensors that record walking patterns, turns, balance and daily activity both in clinic tests and at home, and researchers will build and test algorithms that translate gait speed, step variability and sway into mobility scores and fall risk predictions. As an observational project, it does not change medications but records movement while people use their usual treatments. They are enrolling about 60 people age 50 and up with a Parkinson's diagnosis by a movement disorder specialist using UK Brain Bank criteria, Hoehn and Yahr stages I to III, MoCA score 21 or higher, able to stand and walk unassisted for two minutes, with no other neurological disorders or recent lower limb injury, and who can attend visits in Newcastle upon Tyne.
- Who can participate?
- Participants must be at least 50 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 1 month.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.